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Purpose:Aortoiliac occlusive disease may preclude retrograde thoracic endovascular aortic repair. This study evaluated the
physiologic and anatomic feasibility of introducing an aortic endograft in an antegrade manner into the descending
thoracic aorta of a pig through the left ventricular apex.
Methods: Twelve adult pigs were to undergo antegrade endograft deployment. Under fluoroscopic guidance, a stiff
guidewire was introduced past the aortic valve and into the distal abdominal aorta through the left ventricular apex on
a beating heart. An 18F introducer sheath containing a 24 36-mm aortic endograft was introduced and deployed in the
descending thoracic aorta. The accuracy of graft delivery was determined at necropsy by measuring the distance from the
trailing edge of the graft to the downstream margin of the ostium of the left subclavian artery. Aortic valve competency
was assessed angiographically and at necropsy. Left ventricular function was assessed angiographically. Five hemodynamic
and respiratory variables were recorded at 12 stages during the procedure and assessed for significant changes from
baseline.
Results:One animal died during the sternotomy. All remaining pigs survived the experiment with minimal hemodynamic
support. A significant drop in systolic blood pressure (75 2 to 60 4mmHg, P .05) was noted when the aortic valve
was crossed with an 18F sheath. The systolic blood pressure returned to baseline on endograft deployment and at the end
of the procedure. Bradycardia was noted at several stages of the procedure, requiring treatment in two pigs. Eleven
endografts were deployed; seven grafts were delivered within 5 mm and three grafts within 10 to 20 mm of the intended
landing point. One graft was deployed 10 mm too proximally, covering the left subclavian artery. No aortic valvular
insufficiency or left ventricular dysfunction was noted.
Conclusion: An aortic endograft can be delivered in an antegrade manner transapically into the descending thoracic aorta in a
pig model with a reasonable degree of accuracy and minimal hemodynamic compromise. (J Vasc Surg 2008;48:1301-5.)
Clinical Relevance: This study was performed in a pig model to determine the potential feasibility of performing
endovascular repair of thoracic aortic pathology in humans through the left apex of the heart. Such an alternative route
of endograft delivery might be useful when conventional transarterial access is not available.Despite advancements in large sheath delivery systems,
many patients remain ineligible for endovascular repair of
descending thoracic aortic aneurysms due to aortic, iliac,
and femoral arterial segments that are too stenotic or
tortuous, or both, to ensure safe and accurate graft place-
ment. Adjunctive procedures such as balloon angioplasty of
diseased access arteries and the placement of a surgical
conduit may ensure graft delivery in many patients. How-
ever, these preliminary maneuvers can be extensive and
ultimately unsuccessful.1
Similar problems exist when introducing large
sheaths from the femoral artery to the aortic valve for the
endoluminal implantation of a prosthetic aortic valve for
the treatment of aortic stenosis.2,3 To counter this, our
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through the apex of the left ventricle of the beating
heart.4-6
Recognizing the similar challenges in retrograde trans-
femoral access for both prosthetic aortic valve and thoracic
endograft implantation—and the success in obviating these
difficulties with an antegrade transapical route for pros-
thetic aortic valve placement—we designed this study to
assess the physiologic and anatomic feasibility of transapical
aortic endograft delivery into the descending thoracic aorta
in a pig model.
MATERIALS AND METHODS
The endograft chosen for deployment was the Cook
Main Body Extension graft (ESBE-24-36, Cook Inc,
Bloomington, Ind), a commercially available graft that is
delivered through a nonhydrophilic, straight 18F intro-
ducer sheath. It has a length of 36 mm and a diameter of 24
mm, which was well matched to the size of the descending
thoracic aorta of the pigs that were used. This graft is also
amenable to reloading for multiple deployments, which
considerably reduced the cost of the experiments. Other
commercially available grafts could have been chosen for
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accuracy of graft placement has not been established.
The Animal Care Committee and Institutional Review
Board at the University of British Columbia approved the
experimental protocol. Twelve Yorkshire-Landrace cross
female pigs (53  1 kg) were used in this experiment. The
pigs were orally premedicated with 325 mg of acetylsalicylic
acid and 75 mg of clopidogrel before induction under general
anesthetic with an intramuscular (IM) injection of ketamine
(20 mg/kg). Upon endotracheal intubation, each animal was
mechanically ventilated, using inhaled isoflurane (1% to 4%) to
maintain anesthesia. Systemic buprenorphine (0.01 mg/kg
IM) and 1.3 mL local bupivacaine (0.25%) were administered
for analgesia.
Pigs were placed on a heat-circulating blanket, and the
thorax and abdomen was clipped and intravenous (IV)
access was obtained through an ear vein. Each animal
received a maintenance IV solution of 0.9% normal saline at
100 mL/h. Arterial monitoring was gained through a
catheter placed percutaneously in the right common fem-
oral artery. A cutdown on the left common femoral artery
facilitated retrograde placement of a 5F arterial sheath
(Pinnacle, Terumo Medical Corporation, Elkton, Md).
Full access to the apex of the left ventricle was then
gained through a lower hemisternotomy. The pericardium
was opened and the left ventricular apex identified. Before
cardiac manipulation, using standard angiographic tech-
niques, a pigtail catheter (Softtouch, Merit Medical Sys-
tems, South Jordan, Utah) was advanced retrograde
through the left femoral sheath, into the aortic root, and an
angiogram was performed to assess the preprocedural com-
petency of the aortic valve and to identify the position of the
left subclavian artery. The catheter was then advanced
proximal to the aortic valve, and a ventriculogram was
performed to assess the preprocedural function of the left
ventricle. Two felt-pledgeted U-stitches of 3-0 polypro-
pylene were placed perpendicular to each other, ensuring
full-thickness bites of myocardium. Each U-stitch was
passed through a Rummel tourniquet.
Each animal was systemically anticoagulated with
10,000 U of heparin after sternotomy. Amiodarone was
administered (150 mg IV) to prevent ventricular dysrhyth-
mia, except in instances where bradycardia was observed. If
ventricular dysrhythmia occurred, despite prophylaxis, a
second dose of amiodarone was given. Atropine (0.5 mg
IV) was administered for pronounced intraoperative brady-
cardia.
The Seldinger technique was used to place a 7F Pinna-
cle sheath through the center of the apical sutures, through
the left ventricle, and beyond the aortic valve. Under fluo-
roscopic guidance, a 0.035-inch Bentson wire (Cook Inc)
was advanced through the sheath, around the aortic arch,
and into the distal abdominal aorta. An exchange technique
was used to replace the Bentson wire with a Lunderquist
Extra Stiff wire (Cook Inc). The 7F apical sheath was
exchanged for the 18F introducer sheath, containing the
endograft to be delivered, which was introduced through
the left ventricular apex and advanced under fluoroscopyinto the descending thoracic aorta. Tension placed on the
Rummel tourniquets ensured essentially bloodless intro-
duction of the introducer sheaths into the left ventricle.
The trailing edge of the graft (as loaded onto the intro-
ducer) was positioned adjacent to the left subclavian artery,
as seen on the preprocedural angiogram of the aortic root.
A digitally subtracted aortogram was performed to deter-
mine the precise graft position with respect to the left
subclavian artery. With the objective of landing the trailing
edge of the graft immediately distal to the downstream
margin of the ostium of the left subclavian artery, the device
was deployed. A completion angiogram was performed. All
hardware was removed. Securing the previously placed
pledgeted apical sutures ensured a bloodless closure of the left
ventriculotomy. The ventriculotomy closure site was as-
sessed for bleeding. An aortic root angiogram and left
ventriculogram were repeated to assess for postprocedural
aortic valve competency and left ventricular function.
To assess the physiologic effect of transapical graft
placement, five hemodynamic and respiratory variables
were recorded at 12 stages during the experiment. These
included blood pressure (systolic, diastolic, and mean),
heart rate, and arterial oxygen saturation. Each measure-
ment was recorded at the following experimental stages:
preprocedure with the pig under general anesthesia, at
sternotomy, preangiogram, at placement of the apical su-
ture, at ventricular puncture, at wire crossing of the aortic
valve, at 7F sheath insertion, at 18F sheath insertion, at the
postprocedure angiogram, and postprocedure. Each vari-
able was examined statistically for any significant change
from the preprocedural baseline value.
At the completion of the experiment, each animal was
euthanized with an intravenous bolus of pentobarbital
(150 mg/kg). A necropsy was performed immediately,
with the heart and thoracic aorta removed en bloc. The left
ventricle was examined to assess the security of the ventric-
ulotomy closure, and the aorta was examined for aortic
dissection and intimal injury. The accuracy of graft place-
ment was determined from the necropsy specimen by mea-
suring the distance from the tailing edge of the endograft to
the downstream margin of the ostium of the left subclavian
artery.
Two methods were used to test the competency of the
aortic valve. First, water was applied to the apposed cusps of
the aortic valve specimen, and the competency was noted
by direct observation. The second method was a review of
the preprocedural and postprocedural root aortogram for
angiographic evidence of valvular insufficiency. Left ven-
tricular function was assessed by reviewing the preproce-
dural and postprocedural left ventriculogram.
Physiologic data were analyzed by using paired t tests
(P  .05) with Stata statistical software (StataCorp, LP,
College Station, Tex).
RESULTS
One of the 12 pigs in the study died of a cardiac arrest
during sternotomy, but before angiography or transapical
intervention was performed. Other adverse events included
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induced hypotension in one, treated with volume resusci-
tation; cardiac arrhythmia in one, treated with amiodarone;
and one case of contrast reaction, treated with dexametha-
sone (Table I). Adverse events were managed with the
intent of preventing life-threatening hemodynamic col-
lapse, not to optimize hemodynamic variables.
All 11 remaining animals survived transapical endograft
delivery to the completion of the experiment. Systolic,
diastolic, and mean blood pressure, heart rate, and arterial
oxygen saturation were recorded at 12 stages of the exper-
iment (Table II). Each value tabulated represents a mean of
the values recorded for the 11 remaining pigs in the exper-
iment.
There was a decrease in systolic blood pressure upon
introduction of the 18F introducer sheath across the aortic
valve (P  .05), which resolved upon graft deployment
without the need for fluid or inotropic support. Diastolic
blood pressure increased after ventricular puncture (P 
.02) and at completion of the procedure (P  .0003).
Mean blood pressure had risen by the end of the experi-
ment (P  .01). Significant bradycardia was noted
throughout much of the experiment (P  .05), requiring
atropine administration in two animals. No significant
change occurred in arterial oxygen saturation.
Transapical endograft delivery to the descending tho-
racic aorta was successful in the remaining 11 animals. The
accuracy of graft delivery was measured as the distance
between the trailing edge of the graft and the downstream
margin of the ostium of the left subclavian artery. Seven of
11 grafts were placed at or within 5-mm distal to the
intended landing site. One graft landed 1-cm and two
grafts landed 2-cm distal to the intended landing site. One
graft was deployed 1-cm too proximally, covering the left
subclavian artery. On average, the aortic endograft landed
5.5 mm from the intended landing site (Table III).
No aortic dissections or gross intimal lesions were noted
at necropsy. No aortic valvular incompetency was noted at
Table I. Adverse events and management in 12 pigs
intended to undergo transapical aortic endograft delivery
Pig Event Management
1 None . . .
2 Cardiac arrest poststernotomy Defibrillation, epinephrine
(unsuccessful)
3 Allergic reaction to contrast Dexamethasone
4 Frequent PVCs Amiodarone (150 mg IV)
5 Hypotensiona Volume resuscitation
6 None . . .
7 None . . .
8 None . . .
9 Bradycardia Atropine
10 None . . .
11 None . . .
12 Bradycardia Atropine
IV, Intravenous; PVC, premature ventricular contraction.
aLikely secondary to anaesthesia.necropsy, and no aortic valvular insufficiency was noted on thepreprocedural or postprocedural aortogram. Normal left ven-
tricular function was noted on all preprocedural and postpro-
cedural ventriculograms.
No angiography of the left anterior descending artery
was performed to rule out coronary artery damage on
completion of any experiment because this has not been a
recognized complication of transapical aortic valve replace-
ment. The pledgeted suture closure of the left ventriculot-
omy was secure in all cases, both intraoperatively and on
necropsy.
DISCUSSION
Despite design improvements in delivery systems for
endovascular grafts, hostile arterial anatomy in the aorta,
iliac, or femoral arteries can preclude access from the
groin.1 This may be especially true for thoracic endovascu-
lar aortic repair, because the delivery sheaths involved can
be larger and the distance to be traversed is longer than for
abdominal aortic endografting. This is also true for the
transfemoral approach to prosthetic aortic valve replace-
ment, which requires a larger delivery system than thoracic
endovascular repair and must traverse an even longer dis-
tance.2,3
To overcome the problems of access, the antegrade,
transapical approach to aortic valve replacement has been
developed.4-6 In this procedure, an antegrade approach
through the apex of the heart has been used. The left
ventricular apex is exposed through a 5-cm thoracotomy. A
stiff guidewire is placed through the left ventricular apex,
past the stenotic native aortic valve, and into the descend-
ing thoracic aorta. The prosthetic valve is mounted on its
delivery balloon and is introduced through a 24F sheath
into the left ventricle and onto the aortic annulus.
Given the success of transapical prosthetic aortic valve
replacement, we chose to study the feasibility of transapical
thoracic endograft repair in a pig model. It is recognized
that some differences exist between the two procedures and
that there are some limitations in generalizing the porcine
model to the human. The human minithoracotomy, which
is necessary to gain access to the left-of-center left ventric-
ular apex in transapical aortic valve replacement, was not
possible in our pig model because of the midline orienta-
tion of the pig heart. Furthermore, the proportionally
smaller heart and descending thoracic aorta of a pig neces-
sitated the use of a smaller diameter endograft than would
be used in most human aortas.
Another significant difference between transapical pros-
thetic aortic valve replacement and the procedure we de-
scribe here is that transapical endovascular aortic graft
placement requires a prolonged crossing of the native aortic
valve with large sheaths and delivery catheters. In humans,
this procedure would require sheaths of 20F to 22F to cross
the aortic valve for much of the procedure. In our study,
however, an 18F sheath across a normal pig aortic valve is
tolerated well, producing only transient systolic hypoten-
sion. This hypotension resolved after graft deployment,
despite the presence of an 18F delivery catheter still span-
ning the aortic valve.
red t t
JOURNAL OF VASCULAR SURGERY
November 20081304 Grenon et alThe area of the aortic valves crossed in this experiment
was estimated angiographically to be 2.8 cm2, which is
smaller than the 3.2 to 4.6 cm2 area of a normal human
aortic valve.7 Given the area of a normal human aortic valve,
the sheath to aortic valve area ratio in this experiment is
proportional to one that would be required in attempting
transapical thoracic endovascular aortic repair in a human.
Because it is physiologically feasible to deliver a thoracic
endograft into the descending thoracic aorta of a pig,
transapical thoracic endovascular repair in the human with
a normal aortic valve area might well be possible.
In this study, all 11 endografts were successfully de-
ployed in the descending thoracic aorta, with seven being
deployed within 5 mm of the intended landing point.
Three grafts were implanted 10 to 20 mm distal to the
intended landing point, and one graft covered the left
subclavian artery. Owing to budgetary considerations, the
aortic endografts were reloaded and deployed multiple
Table II. Hemodynamic variables for 11 pigs undergoing
Variable Preprocedure Sternotomy
Prep
ang
BP, mm Hg
Systolic 75  2 74  3 75
Diastolic 39  1 38  3 43
Mean 52  2 51  3 56
HR, beats/min 77  5 70  5 63
SaO2, % 91  6 91  2 90
Variable
7F sheath
insertion
18F sheath
insertion Deplo
BP, mm Hg
Systolic 71  6 60  4a 65
Diastolic 40  2 38  2 40
Mean 48  3 45  2 50
HR, beats/min 62  3a 71  2 68
SaO2, % 89  2 94  1 90
BP, Blood pressure; HR, heart rate; SaO2, arterial oxygen saturation.
aSignificant change from preprocedural baseline value as determined by pai
Table III. Deviation of aortic endograft from intended
landing site noted at necropsy
Pig Landing site deviation, mm
1 5
2 N/A
3 0
4 10
5 20
6 –10
7 0
8 5
9 5
10 0
11 20
12 5
N/A, Not applicable.times. Furthermore, most graft deployments did not ben-efit from the presence of an intact distal trigger wire to
enhance accuracy. In the future, commercially available
thoracic endografts could be reverse-loaded for transapical
delivery, retaining all the advantages that trigger wires and
pristine delivery systems were designed to confer on the
accuracy of graft placement. Such products could only
improve on the accuracy of graft delivery demonstrated in
this study.
In addition, given the absence of any identifiable valvu-
lar, ventricular, or aortic injury or dysfunction, the transapi-
cal delivery of a thoracic endograft is anatomically feasible
in a pig model. Although unknown human variables, such
as cardiac motion and the need to navigate a 180° loop,
may effect the clinical application and accuracy of graft
placement, transapical thoracic endovascular aortic repair in
humans might be possible as well.
The Department of Health and Welfare, Canada, has
approved transapical aortic valve replacement for compassion-
ate clinical use in patients who are not candidates for conven-
tional surgery or transfemoral valve replacement. Given the
clinical success of transapical aortic valve replacement, and this
study’s successful adaptation of transapical access for aortic
endograft delivery, we suggest that transapical thoracic endo-
vascular aortic repair might be considered for similar compas-
sionate use in patients with severe aortic, iliac, and femoral
artery occlusive disease, and life-threatening pathology of the
descending thoracic aorta that is otherwise amenable to endo-
vascular repair and normal aortic valve function.
CONCLUSION
An aortic endograft can be delivered in an antegrade
manner through the beating left ventricular apex into the
descending thoracic aorta in a pig model with a reasonable
sapical aortic endograft delivery
ral
m Apical suture
Ventricular
puncture
Crossing aortic
valve
67  6 75  5 73  6
40  3 44  1a 42  2
51  4 55  2 50  3
a 65  3a 66  3a 66  2
91  1 89  2 89  3
t
Ventricular
closure
Postprocedural
angiogram Postprocedure
71  4 76  4 78  3
43  2 44  1a 47  2a
47  5 56  2 57  1a
67  3a 68  2a 70  4
90  2 90  2 90  2
est analysis (P .05).tran
rocedu
iogra
 4
 3
 4
 4
 2
ymen
 5
 2
 3
 3
 2degree of accuracy and minimal hemodynamic compromise.
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